Who invested in Lyndra Therapeutics?
Lyndra Therapeutics's investors include Invus, Polaris Partners, Gates Foundation, Gilead Sciences and Orient Life, and 1 more on record.

United States · Series E startup
Funding summaryUpdated 26 Oct 2026
$156Mraised across 2 rounds since 2019, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recordedSEC filing: $123M sold, first sale Dec 2023
Reported by FinSMEs
From the SEC filings it signed: 1 on the team.
On the board, as filediAmy SchulmanAshish S. SinghCarlo Giovanni TraversoCatherine S. ReynoldsDoug S. DachilleHelene S. MadonickPatricia S. HurterRobert S. LangerZafi S. Avnur
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Lyndra Therapeutics's investors include Invus, Polaris Partners, Gates Foundation, Gilead Sciences and Orient Life, and 1 more on record.
Lyndra Therapeutics has raised $156M across 2 rounds since 2019.
Lyndra Therapeutics's most recent round was a Series E of $101M in Dec 2023.
Its most recent round, $101M in Dec 2023, is also its largest on record.
Lyndra Therapeutics's first round on record, in Jan 2019, was backed by Invus, Gates Foundation and Gilead Sciences and 2 others.
Lyndra Therapeutics's latest named round is a Series E, in Dec 2023.
Lyndra Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.